ArticleCancer gene therapy2021
An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway.
Jingyao Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this paperpooled itcites it